Net Cash Provided by (Used in) Operating Activities |
-7.09M |
USD |
-1219% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
11.5M |
USD |
+501% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
2.68M |
shares |
-0.78% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
4.44M |
USD |
+73.9% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.28M |
USD |
-31.9% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.3M |
USD |
-3.84% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
3.4M |
USD |
-12.8% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
3.94M |
USD |
+37.3% |
Q4 2022 |
FY 2022 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
191M |
USD |
+1.16% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
Q2 2024 |